USFDA accepts regulatory submission for Pfizer alopecia areata treatment Ritlecitinib Ruchika Sharma10 Sept 2022 5:15 PM ISTAlopecia areata is an autoimmune disease that has an underlying immuno-inflammatory pathogenesis and develops when the immune system attacks the...
Pfizer secures USFDA Breakthrough Therapy designation for Group B Streptococcus Vaccine Ruchika Sharma8 Sept 2022 1:00 PM ISTGroup B Streptococcus (GBS) is a common bacterium that can cause potentially devastating diseases in infants, including sepsis, pneumonia and...
Pfizer-BioNTech bivalent booster for Omicron, original COVID strain gets UK nod Ruchika Sharma5 Sept 2022 12:45 PM ISTIn each dose of the booster vaccine called "Comirnaty bivalent Original/Omicron", half of the vaccine (15 micrograms) targets the original virus...
Pfizer-BioNTech gets USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine booster for 12 years and older Ruchika Sharma2 Sept 2022 2:00 PM ISTThe Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech's proprietary mRNA technology, was developed by both BioNTech and Pfizer.
Alleging patent infringement, Moderna sues Pfizer-BioNtech over use of mRNA technology in COVID vaccine Ruchika Sharma27 Aug 2022 5:00 PM ISTPfizer said the company was confident in its intellectual property and would vigorously defend against the allegations.
COVID vaccine 73.2 percent effective in children under 5: Pfizer Ruchika Sharma24 Aug 2022 4:30 PM ISTThe Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech's proprietary mRNA technology, was developed by both BioNTech and Pfizer.
Pfizer, BioNTech seek USFDA emergency use nod for Omicron adapted COVID booster dose for 12 years of age and older Ruchika Sharma23 Aug 2022 11:32 AM ISTThe bivalent vaccine contains mRNA encoding the original SARS-CoV-2 spike protein, which is present in the original Pfizer-BioNTech COVID-19 Vaccine,...
Test second Paxlovid course in patients with COVID rebound: USFDA asks Pfizer Ruchika Sharma21 Aug 2022 11:30 AM ISTBengaluru: The U.S. Food and Drug Administration (USFDA) has asked Pfizer Inc to test the effects of an additional course of its antiviral Paxlovid...
Pfizer COVID booster gets Canadian nod for kids 5-11 Ruchika Sharma20 Aug 2022 10:30 AM ISTOttawa: Canada's health ministry on Friday said it had authorized the use of Pfizer Inc's and BioNTech's COVID-19 vaccine as a booster for children...
Pfizer CEO Albert Bourla tests COVID positive Ruchika Sharma16 Aug 2022 3:39 PM ISTNew York: Pfizer Inc Chief Executive Officer Albert Bourla has said that he had tested positive for COVID-19 and was experiencing very mild...
EMA starts rolling review of Pfizer-BioNTech variant-adapted COVID vaccine Ruchika Sharma11 Aug 2022 3:45 PM ISTNew Delhi: The European Medicines Agency (EMA) has started a rolling review of a variant-adapted COVID-19 vaccine from Pfizer and BioNTech, it said on...
S Sridhar resigns as MD of Pfizer Ruchika Sharma11 Aug 2022 12:30 PM ISTNew Delhi: Drug firm Pfizer has announced that its Managing Director S Sridhar has resigned from the company. Sridhar has expressed his intention to...
